MEB ASX Chart
Snapshot
Medibio Limited (MEB, formerly BioProspect Limited) is a medical technology company that conducts clinical research, product development and early stage commercialization of a mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | -14.83% |
vs ASX 200 (1yr) | -11.58% |
Key Fundamentals
Shares Issued | |
Sector | Healthcare |
Similar Companies | - |
EPS | $0.00 |
DPS | $0.00 |
Book Value Per Share | $0.00 |
Broker Consensus
MEB is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.
Announcements
Corporate Overview
Corporate Details
Head Office | Mount Lawley WA 6050 |
Website | www.medibio.com.au |
Registry | Computershare |
Auditor | William Buck (Qld) Pty Ltd |
Date Listed | 29 Jan 2001 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
30/01/2024 | Report (Quarterly) |
23/02/2024 | Report (Interim) |
29/08/2024 | Report (Prelim) |
27/09/2024 | Report (Annual) |
Former Company Names
- Bioprospect Limited (BPO), 28/11/2014
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
MEB directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of MEB directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
FIL Limited and the entities | 16/08/2023 | 506,334,415 | 8.30 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
16-08-23 | FIL Limited and the entities | 91,690,095 | 9.99 | 8.30 |
21-02-23 | FIL Limited and the entities | 198,650,369 | 7.84 | 9.99 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.002 | 29 September |
2023 | $0.001 | 30 June |
2022 | $0.002 | 30 June |
2021 | $0.007 | 30 June |
2020 | $0.006 | 30 June |
2019 | $0.009 | 28 June |
2018 | $0.135 | 29 June |
2017 | $0.36 | 30 June |
2016 | $0.325 | 30 June |
2015 | $0.30 | 30 June |
2014 | $0.003 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.